Abstract

Mechanisms inherent in living organisms that are based on the signalling function of the external receptor zones are probably the most accurate signalling system ever existing. These zones hold a potential to relay information regarding incipient pathological alterations within organs at the disease nascent stages. The contemporary iridology considers the iris as one of five receptor zones endowed with a capability to “inform” about changes within the organism, often long before clinical symptoms are manifested. This study aimed to examine the iris potential to provide information on a presence of tumors in the organs on the example of breast tumour.

During a prospective comparative study of the mammographic, ultrasound and iridological method efficiency in diagnostics of benign and malignant breast tumors, were analyzed 305 female patients (including 10 persons is a comparison group) treated for newly diagnosed benign and malignant breast tumour at an oncology center. It is the first time when a comparative iridological instrumental and morphological correlations were drawn that resulted in a clarified breast topography on the right and left iris; a specific criterion named a T-Criterion was defined that is a marker indicative of breast tumors on the iris (the data is not disclosed due to a pending patent process) and has two degrees of manifestation: T1-Criterion representing changes on an iris that are more likely associated with benign tumors with no cellular proliferation; and T2-Criterion representing changes on the iris that are more likely associated with benign tumors with cellular proliferation, cellular atypia present, as well as tissues with adenocarcinoma cells. The sensitivity of the T2-Criterion-based iridological method was 85.7%, which is comparable with mammography results (87%) and surpasses considerably the ultrasound techniques (69%).

The outcomes of this study have allowed assuming that a certain correlation exists between the nature of structural changes in the breast tissue and responsive changes in the iris structure. These findings prompt reconsidering the iris potential as a possible tumor biomarker.

Author: Natallia Ivanova

Iridology Association of Medical Practitioners

Download full abstract:   https://iridology-research.com/pdf/ssrn_id4834841_code6728852.pdf